Upstream & Downstream Processing
From zero to $250m: Agilent aims to dominate cell analysis space![](https://eu-images.contentstack.com/v3/assets/blt0a48a1f3edca9eb0/blt1d79be959c5389cc/658aecbecf3c2e040a808b9f/bioanalysis-analysis121980.jpeg?width=700&auto=webp&quality=80&disable=upscale)
Upstream & Downstream Processing![](https://eu-images.contentstack.com/v3/assets/blt0a48a1f3edca9eb0/blt1d79be959c5389cc/658aecbecf3c2e040a808b9f/bioanalysis-analysis121980.jpeg?width=700&auto=webp&quality=80&disable=upscale)
From zero to $250m: Agilent aims to dominate cell analysis spaceFrom zero to $250m: Agilent aims to dominate cell analysis space
With potentially three acquisitions within nine months, Agilent Technologies has rapidly grown its presence in the cell analysis space.